The Manufacturers Life Insurance Company Invests $124.47 Million in Astera Labs, Inc. $ALAB

The Manufacturers Life Insurance Company bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 257,702 shares of the company’s stock, valued at approximately $124,475,000. The Manufacturers Life Insurance Company owned 0.15% of Astera Labs as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in the company. Reflection Asset Management acquired a new position in Astera Labs during the 4th quarter worth approximately $25,000. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs in the 2nd quarter valued at $25,000. Smartleaf Asset Management LLC lifted its position in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs during the 4th quarter worth $33,000. Finally, Whipplewood Advisors LLC grew its stake in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after purchasing an additional 319 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In related news, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the transaction, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This trade represents a 69.38% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 419,244 shares of company stock worth $163,135,169. Insiders own 10.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on ALAB shares. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a research note on Monday, August 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Barclays increased their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Morgan Stanley raised their target price on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Finally, Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $333.00.

Astera Labs Price Performance

Shares of ALAB opened at $282.65 on Wednesday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The stock has a market cap of $49.04 billion, a PE ratio of 139.93 and a beta of 3.84. The firm has a fifty day moving average price of $348.88 and a 200 day moving average price of $247.38.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the company posted $0.44 earnings per share. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.